- Filed
- Mar 14, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Mar 11, 2025 | 2.85M sh |
| Stock Repurchased | Q3 2025 · Jan 31, 2025 | $0 |
| Stock Repurchased | Q3 2025 · Jan 31, 2024 | $791K |
| Long Term Debt | Q3 2025 · Jan 31, 2025 | $34.96M |
| Cash And Equivalents | Q3 2025 · Jan 31, 2025 | $9.45M |
| Cash And Equivalents | Q3 2025 · Apr 30, 2024 | $23.27M |
| Current Liabilities | Q3 2025 · Jan 31, 2025 | $50.17M |
| Current Liabilities | Q3 2025 · Apr 30, 2024 | $40.78M |
| Total Liabilities | Q3 2025 · Jan 31, 2025 | $127.03M |
| Total Liabilities | Q3 2025 · Apr 30, 2024 | $78.56M |
| Current Assets | Q3 2025 · Jan 31, 2025 | $108.61M |
| Current Assets | Q3 2025 · Apr 30, 2024 | $96.82M |
| Total Assets | Q3 2025 · Apr 30, 2024 | $134.77M |
| Shares Diluted | Q3 2025 · Jan 31, 2024 | 2.97M sh |
| Shares Diluted | Q3 2025 · Jan 31, 2024 | 2.93M sh |
| Capex | Q3 2025 · Jan 31, 2024 | $3.39M |
| Operating Cash Flow | Q3 2025 · Jan 31, 2024 | $18.42M |
| Stockholders Equity | Q3 2025 · Jan 31, 2024 | $44.08M |
| Stockholders Equity | Q3 2025 · Oct 31, 2023 | $42.11M |
| Stockholders Equity | Q3 2025 · Jul 31, 2023 | $39.43M |
| Stockholders Equity | Q3 2025 · Apr 30, 2023 | $37.41M |
| Eps Diluted | Q3 2025 · Jan 31, 2024 | $0.85 |
| Eps Diluted | Q3 2025 · Jan 31, 2024 | $2.64 |
| Eps Basic | Q3 2025 · Jan 31, 2024 | $0.87 |
| Eps Basic | Q3 2025 · Jan 31, 2024 | $2.68 |
| Net Income | Q3 2025 · Jan 31, 2024 | $2.52M |
| Net Income | Q3 2025 · Jan 31, 2024 | $7.73M |
| Net Income | Q3 2025 · Oct 31, 2023 | $2.73M |
| Net Income | Q3 2025 · Jul 31, 2023 | $2.47M |
| Operating Income | Q3 2025 · Jan 31, 2024 | $3.81M |
| Operating Income | Q3 2025 · Jan 31, 2024 | $12.72M |
| Gross Profit | Q3 2025 · Jan 31, 2024 | $12.03M |
| Gross Profit | Q3 2025 · Jan 31, 2024 | $37.41M |
| Cost Of Revenue | Q3 2025 · Jan 31, 2024 | $34.75M |
| Cost Of Revenue | Q3 2025 · Jan 31, 2024 | $109.64M |
| Revenue | Q3 2025 · Jan 31, 2024 | $46.78M |
| Revenue | Q3 2025 · Jan 31, 2024 | $147.05M |